Christa Pike, the only woman on Tennessee’s death row, is facing renewed medical and legal scrutiny after surviving a failed lethal injection that her attorneys say unfolded in precisely the way they had warned state officials it might.

Pike, 50, has a rare blood disorder known as myeloproliferative disorder, which is associated with abnormally elevated platelet levels. Her attorneys have argued that the condition, combined with her small and difficult-to-access veins, could make Tennessee’s lethal injection procedure especially dangerous and increase the risk of severe complications.

Their concerns were raised months before her scheduled execution. They warned that the combination of her medical condition and the state’s execution protocol could lead to serious problems with intravenous access and potentially cause pulmonary edema, a condition in which fluid accumulates in the lungs and can severely interfere with breathing.

On September 30, 2026, Tennessee attempted to carry out Pike’s execution using pentobarbital. But the procedure did not result in her death. Instead, she received two doses of the drug, experienced serious complications and was transported to a hospital in critical condition.

Her attorneys later described repeated failed attempts to establish intravenous lines, severe pain in her arms and signs that she was struggling to breathe. Pike remained unconscious and on a ventilator for several days before gradually recovering.

The failed execution has raised difficult questions about Tennessee’s preparation, medical procedures and ability to carry out its death sentences safely and lawfully.

It has also brought renewed attention to the warnings her legal team had presented before the execution — particularly their concerns about her rare blood disorder.

A RARE BLOOD DISORDER THAT HER LAWYERS SAY COULD MAKE EXECUTION MORE DANGEROUS
According to court filings, Pike has been diagnosed with thrombocytosis associated with a myeloproliferative disorder, a rare form of blood cancer involving abnormal production of blood cells in the bone marrow.

One of the defining features of her condition is an unusually high platelet count.

Platelets are blood components that help the body form clots and stop bleeding. When their levels become abnormally elevated, the condition can create complications involving the body’s clotting system.

Pike’s attorneys argued that her condition could make the state’s lethal injection procedure particularly risky.

Their concern was not limited to the medication itself. They also questioned whether the execution team could reliably establish the intravenous access required to administer the drugs.

The attorneys argued that her veins were small and compromised, making it difficult to insert and maintain IV lines. They also cited the fact that medical staff had used a 23-gauge butterfly needle when drawing her blood because of the difficulty accessing her veins.

The legal team raised another serious concern: the possibility of pulmonary edema.

Pulmonary edema occurs when fluid builds up in the lungs, making it difficult for oxygen to pass into the bloodstream. Severe cases can cause extreme respiratory distress.

Pike’s attorneys argued that her blood condition could increase the risk or severity of this complication during a pentobarbital execution.

They also raised concerns about the possibility of unnecessary pain and suffering if the medication did not enter her bloodstream properly.

These were arguments presented by the defense, not a final judicial finding that the execution would necessarily cause those complications. Tennessee officials disputed the defense’s assessment and maintained that the state’s procedure could be carried out successfully.

Nevertheless, the warnings became especially significant after the September 30 attempt ended with Pike hospitalized rather than pronounced dead.

MONTHS OF LEGAL WARNINGS BEFORE THE SEPTEMBER EXECUTION
Pike’s medical condition was central to a legal challenge filed before her scheduled execution.

Her attorneys argued that Tennessee’s lethal injection protocol did not adequately account for individual medical conditions, physical characteristics or psychological circumstances that could affect the execution process.

They maintained that the state was planning to use a standard procedure without sufficiently addressing Pike’s particular risks.

The challenge also raised questions about the qualifications and preparation of the personnel responsible for establishing IV access.

The issue became more urgent after another Tennessee execution attempt involving death row inmate Tony Carruthers was halted in May 2026.

Carruthers’ execution was abandoned after officials encountered difficulties establishing the required intravenous access. Pike’s attorneys pointed to that incident as evidence that the state’s procedures and personnel could face serious problems when confronted with difficult IV placement.

In August, a court held a multi-day evidentiary hearing to examine the issues surrounding Pike’s execution.

The hearing considered several questions, including whether her blood disorder created a substantial risk of complications, whether the state’s protocol adequately addressed her medical needs and whether alternative methods or procedures could reduce the risk of severe suffering.

Her attorneys proposed using a smaller butterfly needle, arguing that trained medical personnel could use it to establish more reliable IV access.

They also raised concerns about her psychological history and the impact of being handled by an all-male execution team.

The state disputed the defense’s claims. Its attorneys argued that Pike’s medical evidence did not establish that she would face the level of serious harm required to block an execution under constitutional standards.

The court did not ultimately prevent the September 30 execution from proceeding.

That decision would soon become a major point of controversy.

SEPTEMBER 30: THE EXECUTION THAT DID NOT GO AS PLANNED
Pike was scheduled to be executed at Riverbend Maximum Security Institution in Nashville on September 30.

The procedure was delayed for several hours while final legal challenges were considered. Eventually, the execution team began preparing her for the lethal injection.

According to a later court declaration from attorney Randy Spivey, who witnessed the procedure, the team began attempting to establish the required IV lines at approximately 6:34 p.m.

Tennessee’s protocol required two IV lines.

The first line in Pike’s right arm was reportedly established relatively quickly. The second, in her left arm, proved much more difficult.

The team spent close to an hour attempting to locate a suitable vein.

Spivey’s account described repeated attempts, uncertainty among the personnel and concerns that some of Pike’s veins may have been damaged or had effectively ruptured.

At one point, a member of the team reportedly questioned whether a vein was beginning to blow. Another attempt involved a needle that appeared severely bent when it was removed.

The attorney’s declaration said approximately 10 needles were used during the process.

Pike reportedly grimaced and appeared uncomfortable as the team continued trying to establish access.

The difficulties were particularly troubling because her attorneys had previously warned that her veins could make the procedure unusually challenging.

Eventually, the team appeared satisfied that the lines had been established, and the execution proceeded.

But the problems did not end there.

PIKE REPORTED BURNING PAIN AS THE DRUG WAS ADMINISTERED
According to Spivey’s account, Pike began complaining about pain in her arm after the medication was administered.

At approximately 7:34 p.m., she reportedly told those present that her arm felt as though it was about to burst and that it was burning.

Her attorneys later described the statement as evidence that something may have gone seriously wrong with the IV access.

One possible complication discussed in the subsequent legal filings was IV infiltration. This occurs when fluid or medication escapes from a vein and enters surrounding tissue instead of remaining inside the bloodstream.

If a medication is not delivered properly, the procedure may not work as intended. Depending on the substance and the extent of the leakage, the surrounding tissue can also suffer significant injury.

Pike’s attorneys said her arms were swollen, burned and blistered when she arrived at the hospital.

The witnesses also described changes in her breathing.

Spivey’s declaration said Pike began making unusual snoring sounds and later appeared to struggle with her breathing. Her body reportedly moved and flinched during the period after the medication was administered.

The execution team gave her a second dose of pentobarbital under the state’s protocol.

But Pike remained alive.

The attorney said he became increasingly concerned as the procedure continued and ultimately sought intervention because the protocol did not authorize a third dose.

By then, the situation had moved far beyond an ordinary execution procedure.

THE MOMENT HER ATTORNEYS REALIZED SHE WAS STILL ALIVE
One of the most disturbing details in the later court filings involved the length of time between the administration of the medication and the decision to obtain emergency medical assistance.

According to Spivey’s declaration, he contacted other attorneys at approximately 8:22 p.m. and urged them to intervene because Pike had not died and another dose was not permitted under the protocol.

He then informed a deputy attorney general that Pike needed immediate medical care.

An ambulance was requested, and prison personnel began arranging emergency assistance.

The attorney’s account placed the ambulance’s arrival at the hospital at approximately 9:14 p.m.

Pike was transported for treatment rather than pronounced deceased.

Her survival made the incident particularly unusual. The Death Penalty Information Center described her case as the first reported instance of a person surviving after receiving the full sequence of lethal injection medications under an execution protocol.

The incident immediately raised questions about what happens when an execution does not produce the expected result.

Tennessee’s protocol provided for a second dose if the first did not result in death, but it did not clearly establish a comprehensive medical rescue procedure for a person who remained alive after the second dose.

That gap became a major issue in the legal debate that followed.

HOSPITALIZED, UNCONSCIOUS AND ON A VENTILATOR
In the days following the failed execution, Pike remained in critical condition.

Her attorneys said she was unconscious and required a ventilator to support her breathing.

They also reported serious injuries to both arms, including swelling, burns and blistering associated with the medication administration.

Medical staff worked to treat the effects of the pentobarbital and manage the complications she had suffered.

Her legal team said there had been periods when they feared she might not survive.

On October 6, her attorneys reported that she had regained consciousness.

Her recovery, however, did not mean that the physical and psychological consequences of the attempted execution had ended.

Pike later described waking up confused and in pain after several days in the hospital.

In her first public statement following the incident, she said she had entered the execution chamber prepared to die. She also expressed anger over what she described as the incompetence that had placed her and others in such a difficult position.

Her statement added a personal dimension to a case that had largely been discussed through medical records, court filings and official explanations.

She had been prepared for the execution to end her life. Instead, she woke up in a hospital after surviving a procedure that her attorneys say exposed her to precisely the dangers they had identified in advance.

WHY PULMONARY EDEMA BECAME A CENTRAL ISSUE
The concern about pulmonary edema is one of the most important medical questions in Pike’s case.

The condition develops when excess fluid accumulates in the lungs. As the fluid builds up, the lungs become less effective at transferring oxygen into the bloodstream.

Severe pulmonary edema can cause shortness of breath, a feeling of suffocation and potentially life-threatening respiratory failure.

Pike’s attorneys argued that her elevated platelet count and underlying blood disorder could make her more vulnerable to serious complications during a pentobarbital execution.

They also cited medical literature and prior executions in which pulmonary edema had been identified during post-execution examinations.

The defense argued that the state should have considered those risks when deciding whether its standard procedure was appropriate for Pike.

Tennessee officials, however, disputed the claim that her condition made the execution unconstitutionally dangerous.

The disagreement is significant because the legal question is not simply whether an inmate has a medical condition. Courts must consider whether the proposed execution method creates a substantial risk of serious harm and whether a feasible alternative would meaningfully reduce that risk.

Pike’s attorneys maintain that the state failed to address her individual medical circumstances adequately.

The state has maintained that its protocol was lawful and that officials followed the established procedure.

The failed execution has made those competing positions much harder to separate from the actual events that took place in the chamber.

TENNESSEE ORDERS A REVIEW AND HALTS OTHER EXECUTIONS
The consequences of Pike’s failed execution extended beyond her individual case.

Following the September 30 incident, Tennessee Governor Bill Lee ordered a temporary halt to the state’s remaining scheduled executions for 2026.

Lee also announced an independent review to determine what happened during the attempted execution and whether the state’s procedures were followed.

The review is intended to examine the execution process and consider whether changes are needed to ensure the protocol is lawful and effective.

The incident also contributed to leadership changes within the Tennessee Department of Correction. Commissioner Frank Strada announced his resignation in October.

The state has faced renewed scrutiny over its execution procedures, particularly the training of personnel responsible for intravenous access and the absence of a clearly defined response when an inmate survives the full medication sequence.

Pike’s case is now part of a wider debate over whether Tennessee’s lethal injection system can reliably carry out executions without exposing prisoners to unnecessary pain and suffering.

The review does not itself determine whether Pike’s death sentence will be overturned or whether she will eventually face another execution attempt.

Those questions remain subject to separate legal and executive decisions.

A NEW LEGAL DISPUTE OVER HER PRISON CONDITIONS
Even after returning from the hospital, Pike’s situation remained complicated.

She was transferred back into the Tennessee prison system and placed in the medical unit while recovering.

Her attorneys have argued that continued isolation in the infirmary amounts to an unacceptable form of confinement and violates protections established in an earlier settlement with corrections officials.

They have also expressed concern about her physical weakness, access to medical care and the possibility of returning to a prison unit where she says she previously experienced assaults and psychological distress.

Pike has asked to be moved to a different housing arrangement that she considers safer.

The state has opposed her request.

In a court filing reported on November 5, Tennessee officials argued that Pike still requires around-the-clock medical care available in the infirmary and that her housing assignment is a decision for prison authorities.

State attorneys also cited her maximum-security classification, previous conduct and security concerns as reasons not to transfer her to the specialized unit she requested.

The state disputes her characterization of the infirmary as solitary confinement, arguing that she can interact with staff, use communication devices and request visits.

The disagreement illustrates that Pike’s legal battle has expanded beyond the original question of whether Tennessee can execute her under its current protocol.

Her attorneys are now also challenging how she is being housed and treated after surviving the failed procedure.

THE 1995 CRIME THAT PUT HER ON DEATH ROW
Pike’s case has drawn national attention because she is the only woman on Tennessee’s death row and because her attempted execution was the state’s first planned execution of a woman in more than two centuries.

But the legal proceedings cannot be understood without the crime that originally led to her death sentence.

In 1995, when she was 18 years old, Pike was involved in the brutal killing of 19-year-old Colleen Slemmer, a fellow student.

Pike and her boyfriend, Tadaryl Shipp, were convicted in connection with the crime.

Slemmer was tortured and stabbed in a wooded area near Knoxville, Tennessee. The attack involved extreme violence, and prosecutors presented evidence describing the prolonged nature of the assault.

Pike was convicted of first-degree murder and sentenced to death.

Her case became one of the most notorious criminal cases in Tennessee because of the victim’s age, the brutality of the killing and Pike’s age at the time.

She has remained on death row for decades while pursuing various legal challenges.

The current dispute over her medical condition does not erase the conviction or determine whether she is guilty of the 1995 crime. It concerns the constitutionality and implementation of the state’s method of execution.

That distinction is central to the ongoing legal proceedings.

WHAT HAPPENS NEXT FOR CHRISTA PIKE?
As of November 6, 2026, Pike remains alive and in Tennessee custody. Her death sentence has not been publicly overturned, but the September 30 execution attempt has created significant new legal and political complications.

Several issues remain unresolved.

First, the independent review ordered by Governor Lee must examine whether the execution team followed the state’s protocol and why the procedure failed.

Second, courts will continue considering the legal challenges involving Tennessee’s lethal injection process, including the medical risks raised by Pike’s attorneys.

Third, the dispute over her placement in the prison infirmary remains a separate matter that could affect her immediate living conditions while she recovers.

Finally, the state has not announced a new execution date for Pike. The governor’s temporary halt to other scheduled executions and the scrutiny surrounding the failed procedure mean that any future attempt would face substantial legal and procedural questions.

For now, the case stands as an extraordinary example of what can happen when an execution procedure fails after the lethal drugs have already been administered.

Pike’s attorneys insist that the outcome was not unpredictable. They argue that her rare blood disorder, elevated platelet count and difficult veins had been identified as serious risks months before September 30.

Tennessee officials have defended the legality of their procedure, but the events inside the execution chamber have intensified questions about whether the state was adequately prepared for her medical circumstances.

The central issue is no longer only whether Christa Pike will face another execution attempt. It is also whether Tennessee can demonstrate that its procedures are capable of carrying out a death sentence without repeating the medical and operational failures that left her unconscious in a hospital after two doses of lethal medication.